azelastine has been researched along with olopatadine hydrochloride in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (93.33) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bensch, G; Berdy, GJ; Spangler, DL | 1 |
| Athanasiou, A; Boucher, W; Fitzgerald, K; Huang, M; Jeudy, S; Kandere, K; Kempuraj, D; Letourneau, R; Spear, K; Theoharides, TC | 1 |
| Akagi, M; Fukuishi, N; Iwanaga, M; Matsuhisa, M; Matsui, N; Murata, N; Sagara, H; Shimono, T | 1 |
| Boucher, W; Esposito, P; Huang, M; Kempuraj, D; Lytinas, M; Theoharides, TC | 1 |
| Blondin, C; Cholley, B; Goldschmidt, P; Haeffner-Cavaillon, N | 1 |
| Bielory, L; Bigelson, S; Buddiga, P | 1 |
| Flynn, TH; Larkin, F; Manzouri, B; Ono, SJ; Wyse, R | 1 |
| Beauregard, C; Gamache, D; Roberts, L; Stephens, D; Yanni, J | 1 |
| Montero, JA; Pastor, S; Rodriguez, AE; Ruiz-Moreno, JM; Sanchis-Merino, ME | 1 |
| Costantini, C; Drake, M; Pipkorn, P; Proud, D; Reynolds, C; Sanico, A; Togias, A; Wall, M | 1 |
| Kim, N; Lee, JE; Lee, JS; Oum, BS | 1 |
| Michael Wall, G; Nayak, A; Ratner, P; Roland, P; Shah, SR | 1 |
| Bonini, S; Lambiase, A; Micera, A | 1 |
| Kaliner, MA | 1 |
| Ben-Eli, H; Solomon, A | 1 |
5 review(s) available for azelastine and olopatadine hydrochloride
| Article | Year |
|---|---|
Ocular allergy treatment comparisons: azelastine and olopatadine.
Topics: Administration, Topical; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Conjunctivitis, Allergic; Dibenzoxepins; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Mast Cells; Olopatadine Hydrochloride; Phthalazines | 2004 |
Pharmacotherapy of allergic eye disease.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Conjunctivitis, Allergic; Cost of Illness; Dibenzoxepins; Drug Administration Schedule; Health Care Costs; Histamine H1 Antagonists; Humans; Immunosuppressive Agents; Mast Cells; Olopatadine Hydrochloride; Phthalazines; Quality of Life; Randomized Controlled Trials as Topic; Tacrolimus; Vision Disorders | 2006 |
Multiple action agents and the eye: do they really stabilize mast cells?
Topics: Animals; Anti-Inflammatory Agents; Arachidonic Acid; Conjunctivitis, Allergic; Cytokines; Dibenzazepines; Dibenzoxepins; Histamine; Histamine Antagonists; Humans; Imidazoles; Immunity, Innate; Ketotifen; Mast Cells; Olopatadine Hydrochloride; Phthalazines | 2009 |
Azelastine and olopatadine in the treatment of allergic rhinitis.
Topics: Administration, Intranasal; Anti-Allergic Agents; Clinical Trials as Topic; Dibenzoxepins; Humans; Olopatadine Hydrochloride; Phthalazines; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Treatment Outcome | 2009 |
Topical antihistamines, mast cell stabilizers, and dual-action agents in ocular allergy: current trends.
Topics: Administration, Ophthalmic; Anti-Allergic Agents; Benzazepines; Conjunctivitis, Allergic; Cromolyn Sodium; Dibenzazepines; Histamine Antagonists; Humans; Hyperemia; Imidazoles; Ketotifen; Nedocromil; Olopatadine Hydrochloride; Phthalazines; Piperidines; Pruritus; Pyridines; Pyrimidinones | 2018 |
3 trial(s) available for azelastine and olopatadine hydrochloride
| Article | Year |
|---|---|
Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model.
Topics: Adult; Anti-Allergic Agents; Conjunctivitis, Allergic; Dibenzoxepins; Double-Blind Method; Female; Humans; Male; Olopatadine Hydrochloride; Ophthalmic Solutions; Phthalazines; Prospective Studies | 2001 |
The effects of the nasal antihistamines olopatadine and azelastine in nasal allergen provocation.
Topics: Adult; Allergens; Anti-Allergic Agents; Conjunctivitis, Allergic; Cross-Over Studies; Dibenzoxepins; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Nasal Provocation Tests; Olopatadine Hydrochloride; Phthalazines; Rhinitis, Allergic, Seasonal | 2008 |
Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Anti-Allergic Agents; Child; Dibenzoxepins; Double-Blind Method; Epistaxis; Female; Humans; Male; Middle Aged; Olopatadine Hydrochloride; Phthalazines; Rhinitis, Allergic, Seasonal; Taste; United States; Young Adult | 2009 |
7 other study(ies) available for azelastine and olopatadine hydrochloride
| Article | Year |
|---|---|
Azelastine is more potent than olopatadine n inhibiting interleukin-6 and tryptase release from human umbilical cord blood-derived cultured mast cells.
Topics: Anti-Allergic Agents; Cells, Cultured; Dibenzoxepins; Dose-Response Relationship, Drug; Fetal Blood; Histamine Release; Humans; Interleukin-6; Lymphocyte Activation; Mast Cells; Olopatadine Hydrochloride; Phthalazines; Serine Endopeptidases; Tryptases | 2002 |
Inhibitory effect of olopatadine on antigen-induced eosinophil infiltration and the LFA-1 and Mac-1 expression in eosinophils.
Topics: Administration, Oral; Animals; Anti-Allergic Agents; Cell Movement; Dibenzoxepins; Eosinophils; Histamine H1 Antagonists; In Vitro Techniques; Integrin alpha4beta1; Lymphocyte Function-Associated Antigen-1; Macrophage-1 Antigen; Male; Nasal Mucosa; Olopatadine Hydrochloride; Phthalazines; Rats; Rhinitis, Allergic, Perennial | 2002 |
Acute stress results in skin corticotropin-releasing hormone secretion, mast cell activation and vascular permeability, an effect mimicked by intradermal corticotropin-releasing hormone and inhibited by histamine-1 receptor antagonists.
Topics: Acute Disease; Animals; Calcium; Capillary Permeability; Corticotropin-Releasing Hormone; Dibenzoxepins; Histamine H1 Antagonists; Histamine Release; Injections, Intradermal; Male; Mast Cells; Olopatadine Hydrochloride; Phthalazines; Rats; Rats, Sprague-Dawley; Restraint, Physical; Skin; Stress, Physiological | 2003 |
[In vitro effects of antiallergic eyedrops on complement activation induced by particulate matter].
Topics: Air Pollutants; Anti-Allergic Agents; Benzalkonium Compounds; Benzimidazoles; Complement Activation; Conjunctivitis; Cosmetics; Dibenzoxepins; Dipeptides; Drug Evaluation; Dust; Humans; In Vitro Techniques; Ketotifen; Nedocromil; Olopatadine Hydrochloride; Ophthalmic Solutions; Oxamic Acid; Phthalazines; Piperidines; Pollen; Silicon Dioxide; Zymosan | 2003 |
Duration of action of topical antiallergy drugs in a Guinea pig model of histamine-induced conjunctival vascular permeability.
Topics: Administration, Topical; Animals; Anti-Allergic Agents; Capillary Permeability; Conjunctiva; Delayed-Action Preparations; Dibenzazepines; Dibenzoxepins; Dose-Response Relationship, Drug; Guinea Pigs; Histamine; Histamine H1 Antagonists; Imidazoles; Ketotifen; Male; Olopatadine Hydrochloride; Ophthalmic Solutions; Phthalazines | 2007 |
Comparative efficacy of topical antihistamines in an animal model of early phase allergic conjunctivitis.
Topics: Animals; Anti-Allergic Agents; Benzimidazoles; Coloring Agents; Conjunctivitis, Allergic; Dibenzoxepins; Dipeptides; Disease Models, Animal; Drug Evaluation, Preclinical; Evans Blue; Guinea Pigs; Histamine H1 Antagonists; Ketotifen; Male; Olopatadine Hydrochloride; Ophthalmic Solutions; Phthalazines; Severity of Illness Index; Treatment Outcome | 2008 |
Comparison of the conjunctival toxicity of topical ocular antiallergic agents.
Topics: Animals; Anti-Allergic Agents; Cells, Cultured; Conjunctiva; Dibenzoxepins; Hydrogen-Ion Concentration; Ketotifen; L-Lactate Dehydrogenase; Microscopy, Electron; Microscopy, Phase-Contrast; Olopatadine Hydrochloride; Phthalazines; Rabbits | 2008 |